Insider · CIK 0001373603

Leonard Braden Michael

Reports to the SEC for 17 companies · ZIONSVILLE, IN

sec.gov

Transactions

Companies

Filings

CIK

0001373603

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-02	OMOutset Medical, Inc.P Purchase	10% Owner	PPurchase	+16.6K sh	$3.88	+$64.2K	2,764,610
2026-10-01	OMOutset Medical, Inc.P Purchase	10% Owner	PPurchase	+228K sh	$3.53	+$806K	2,748,035
2026-05-15	OMOutset Medical, Inc.X Exercise of In-Money	10% Owner	XExercise of In-Money	+323K sh	$5.00	+$1.62M	2,519,701
2026-05-11	OMOutset Medical, Inc.X Exercise of In-Money	10% Owner	XExercise of In-Money	+96.9K sh	$5.00	+$485K	2,196,701
2026-05-08	OMOutset Medical, Inc.X Exercise of In-Money	10% Owner	XExercise of In-Money	+198K sh	$5.00	+$988K	2,099,801
2026-04-23	ACRSAclaris Therapeutics, Inc.S Sale	10% Owner	SSale	−300K sh	$4.53	−$1.36M	13,950,000
2025-12-04	Adverum Biotechnologies, Inc.S Sale	10% Owner	SSale	−525K sh	$4.19	−$2.2M	1,958,080
2025-12-03	Adverum Biotechnologies, Inc.S Sale	10% Owner	SSale	−223K sh	$4.17	−$930K	2,428,640
2025-12-02	Adverum Biotechnologies, Inc.S Sale	10% Owner	SSale	−52K sh	$4.20	−$218K	2,705,565
2025-12-01	Adverum Biotechnologies, Inc.S Sale	10% Owner	SSale	−300K sh	$4.20	−$1.26M	2,757,526
2025-10-03	ASTCASTROTECH CorpS Sale	10% Owner	SSale	−9,166 sh	$5.83	−$53.4K	0
2025-10-03	ASTCASTROTECH CorpS Sale	10% Owner	SSale	−220K sh	$7.13	−$1.57M	0
2025-05-30	ANTXAN2 Therapeutics, Inc.S Sale	10% Owner	SSale	−425K sh	$1.01	−$429K	3,224,432
2025-05-30	ANTXAN2 Therapeutics, Inc.S Sale	10% Owner	SSale	−7,000 sh	$1.03	−$7,226.8	3,217,432
2025-05-28	ANTXAN2 Therapeutics, Inc.S Sale	10% Owner	SSale	−2M sh	$1.16	−$2.32M	3,749,432
2025-05-28	ANTXAN2 Therapeutics, Inc.S Sale	10% Owner	SSale	−100K sh	$1.16	−$116K	3,649,432
2025-05-28	ANTXAN2 Therapeutics, Inc.S Sale	10% Owner	SSale	−200K sh	$1.09	−$218K	3,017,432
2025-04-23	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+50K sh	$2.98	+$149K	191,800
2025-04-22	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+300K sh	$3.00	+$900K	3,057,526
2025-04-02	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+15.2K sh	$4.04	+$61.4K	2,757,526
2025-03-31	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+19.6K sh	$4.38	+$85.7K	2,742,317
2025-03-27	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	−16.6K sh	$5.19	−$86.1K	141,800
2025-03-27	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+16.6K sh	$5.19	+$86.1K	141,800
2025-03-27	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+16.6K sh	$5.19	+$86.1K	141,800
2025-03-26	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+20.4K sh	$5.04	+$103K	125,207
2025-03-26	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+20.4K sh	$5.04	+$103K	125,207
2025-03-26	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+20.4K sh	$5.04	+$103K	125,207
2025-03-20	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+30.6K sh	$5.61	+$172K	2,722,761
2025-03-19	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+25K sh	$4.94	+$123K	2,692,161
2025-03-18	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+44.3K sh	$4.73	+$210K	2,667,161
2025-03-18	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+18K sh	$4.60	+$82.8K	2,622,820
2025-02-28	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+85.1K sh	$4.60	+$391K	2,604,820
2025-02-27	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+86.8K sh	$4.46	+$387K	2,519,752
2025-02-26	Adverum Biotechnologies, Inc.P Purchase	10% Owner	PPurchase	+165K sh	$4.01	+$661K	2,432,950
2024-10-07	OKUROnKure Therapeutics, Inc.J Other	Former 10% owner of RPHM	JOther	+102K sh	—	—	102,076
2024-10-07	OKUROnKure Therapeutics, Inc.J Other	Former 10% owner of RPHM	JOther	+346K sh	—	—	345,739
2024-09-25	OKUROnKure Therapeutics, Inc.P Purchase	Former 10% owner of RPHM	PPurchase	+68.7K sh	$1.50	+$103K	3,457,395
2024-09-24	OKUROnKure Therapeutics, Inc.P Purchase	Former 10% owner of RPHM	PPurchase	+29.6K sh	$1.41	+$41.9K	3,388,649
2024-09-18	OKUROnKure Therapeutics, Inc.P Purchase	Former 10% owner of RPHM	PPurchase	+806 sh	$1.40	+$1,128.4	3,359,049
2024-09-17	OKUROnKure Therapeutics, Inc.P Purchase	Former 10% owner of RPHM	PPurchase	+55.3K sh	$1.36	+$75.1K	3,358,243
2024-09-16	OKUROnKure Therapeutics, Inc.P Purchase	Former 10% owner of RPHM	PPurchase	+173K sh	$1.37	+$237K	3,302,943
2024-09-13	OKUROnKure Therapeutics, Inc.P Purchase	Former 10% owner of RPHM	PPurchase	+150K sh	$1.31	+$197K	3,130,196
2024-09-12	OKUROnKure Therapeutics, Inc.P Purchase	Former 10% owner of RPHM	PPurchase	+36.2K sh	$1.40	+$50.5K	2,980,196
2024-09-06	TLISTalis Biomedical CorpP Purchase	10% Owner	PPurchase	+25K sh	$1.48	+$37.1K	248,702
2024-09-05	TLISTalis Biomedical CorpP Purchase	10% Owner	PPurchase	+5,100 sh	$1.40	+$7,140	223,702
2024-09-03	TLISTalis Biomedical CorpP Purchase	10% Owner	PPurchase	+500 sh	$4.00	+$2,000	218,602
2024-08-30	TLISTalis Biomedical CorpP Purchase	10% Owner	PPurchase	+151 sh	$4.25	+$641.75	218,602
2024-08-28	TLISTalis Biomedical CorpP Purchase	10% Owner	PPurchase	+1,215 sh	$3.96	+$4,814.68	217,951
2024-08-26	TLISTalis Biomedical CorpP Purchase	10% Owner	PPurchase	+13.2K sh	$3.90	+$51.3K	216,736
2024-08-14	ANTXAN2 Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+1.5M sh	$1.04	+$1.56M	5,749,432

Recent filings

Accepted (ET)
Oct 5 19:244
Leonard Braden Michael0001373604-26-000050
SEC(opens sec.gov)
May 184
Leonard Braden Michael0001373604-26-000043
SEC(opens sec.gov)
May 124
Leonard Braden Michael0001373604-26-000036
SEC(opens sec.gov)
Apr 274
Leonard Braden Michael0001373604-26-000034
SEC(opens sec.gov)
Dec 54
Leonard Braden Michael0001373604-25-000122
SEC(opens sec.gov)
Dec 34
Leonard Braden Michael0001373604-25-000118
SEC(opens sec.gov)
Oct 74
Leonard Braden Michael0001373604-25-000106
SEC(opens sec.gov)
Jun 164
Leonard Braden Michael0001373604-25-000090
SEC(opens sec.gov)
May 304
Leonard Braden Michael0001373604-25-000084
SEC(opens sec.gov)
Apr 284
Leonard Braden Michael0001373604-25-000067
SEC(opens sec.gov)
Apr 284/A
Leonard Braden Michael0001373604-25-000069
SEC(opens sec.gov)

Companies

Address

65 E CEDAR - SUITE 2

ZIONSVILLE, IN, 46077